Experimental Therapeutics Medicinal Chemistry

Award Date 1/18/2018
Last Date To Order 1/17/2023
Shared Ceiling $2.5M
Federal Agency
Medical Command
Contract Type
Master IDIQ
Predecessor
Not listed
Successors

The Experimental Therapeutics Medicinal Chemistry Master Indefinite Delivery/Indefinite Quantity (IDIQ) contract is a non-personal services vehicle awarded by the U.S. Army Medical Command for specialized scientific research support. The primary scope involves purification and characterization of organic compounds, specifically targeting experimental therapeutics medicinal chemistry tasks for the Walter Reed Army Institute of Research located in Silver Spring, Maryland. Services under this contract focus on advanced chemical analysis and preparatory work critical to medical and pharmaceutical research initiatives.

Task orders under this IDIQ demonstrate consistent engagement with small and potentially minority-owned businesses, with individual task order values ranging from approximately $17,958 to $141,679. The delivery orders are consistently structured as firm fixed-price contracts, typically with completion periods between 3-9 months. All recent task orders have been awarded to different contractors, suggesting a competitive environment, with Hager Biosciences, LLC being one identified prime contractor. The contract appears to primarily support the Department of the Army Medical Command's research needs, with task order places of performance including locations like Fountain Hill, Pennsylvania. No specific set-aside designations have been utilized in the recorded task orders, indicating an open competition approach for these scientific service requirements.

Generated 1/16/25, 12:05 AM